OXY Ticker (Occidental Petroleum): Stock Price, Business Overview, Warren Buffett Stake, Valuation & Outlook 2025–2026

What Is OXY? — Occidental Petroleum Company Overview

Occidental Petroleum Corporation (NYSE: OXY) is a major U.S. integrated energy company. Founded in 1920 and headquartered in Houston, Texas, OXY operates across three historical business segments: upstream oil and gas exploration & production (E&P), midstream and marketing, and chemical manufacturing (OxyChem — now divested). It is among the top five largest U.S. oil producers by output and one of the dominant operators in the Permian Basin, the most prolific oil-producing region in the United States.

OXY produces crude oil, natural gas, and natural gas liquids (NGLs) from operations in:

• Permian Basin (U.S.): The core of OXY's U.S. production — approximately 800,000 BOE/d following the CrownRock acquisition (Q1 2024). Includes Delaware Basin (New Mexico/Texas) and Midland Basin (CrownRock's primary asset)
• Rockies (U.S.): Operations in Wyoming — significant natural gas and NGL production
• U.S. Gulf operations
• Middle East / North Africa: Long-standing concession agreements in Oman and the UAE — producing approximately 200,000–250,000 BOE/d; lower cost, stable production

OXY is also notable for its Carbon Management (formerly known as Low Carbon Ventures) business — including STRATOS, the world's largest direct air capture (DAC) plant, and enhanced oil recovery (EOR) using CO₂ injection in the Permian Basin.

For context on how OXY fits within broader U.S. energy sector categorizations, InvestSnips documents all 11 GICS sectors and sub-industries across U.S. exchanges — including the integrated oil and gas and E&P sub-industries where OXY is classified.

OXY Business Segments: Oil & Gas, Midstream, OxyChem (Divested)

1. Oil and Gas (Upstream E&P) — Core Segment

OXY's upstream E&P division is the primary driver of earnings and stock performance. Revenue and profitability are directly tied to oil (WTI) and natural gas prices. Post-CrownRock, OXY's total production target for 2026 is approximately 1.45 million barrels of oil equivalent per day (BOE/d) — a significant increase from pre-acquisition levels.

2. Midstream and Marketing

OXY operates gathering, processing, transportation, storage, and marketing infrastructure primarily supporting its own upstream operations. This segment provides some fee-based income stability but is predominantly focused on internal logistics rather than pure third-party midstream services like dedicated MIDSTREAM MLPs.

3. OxyChem (Chemical Division) — Divested to Berkshire ($9.7B, Early 2026)

OxyChem was historically OXY's most stable earnings contributor — a world-class producer of chlorovinyls (PVC, VCM, chlorine) and caustic soda. The chemicals business provided a partial hedge against oil price volatility, generating billions in recurring earnings through commodity cycles. In early 2026, Berkshire Hathaway acquired OxyChem for $9.7 billion — a strategic divestiture that dramatically changes OXY's earnings quality and mix going forward. OXY used the proceeds primarily for debt repayment (target: reduce principal debt to ~$14.3 billion).

OXY Financial Snapshot: Revenue, EPS & Key Metrics (2025–2026)

Sources: MarketBeat, Zacks, Trefis, SimplyWallSt, Investing.com, GuruFocus, Morningstar, OXY SEC filings. All estimates as of early 2026. Financial metrics are dynamic — always verify at primary sources (Macrotrends, OXY investor relations, SEC EDGAR) before making any investment decision.

Warren Buffett & Berkshire Hathaway's OXY Stake Explained

The most distinctive institutional story behind OXY is Warren Buffett's Berkshire Hathaway's massive, multi-layered position — which is far more complex than simply "Buffett bought OXY stock."

Three Layers of the Berkshire OXY Position (as of Dec 2024)

• Common Equity (~28%+ of shares outstanding): Berkshire held approximately 264 million shares of OXY common stock — making it by far the largest common shareholder. At OXY's stock price range of $45–55, this represents an equity stake worth approximately $12–$15 billion. This position was accumulated in multiple tranches from 2019 onward, with aggressive buying in 2022–2023.
• Warrants: Berkshire holds warrants to acquire additional shares of OXY at a fixed exercise price — providing additional upside if OXY's price appreciates significantly. These warrants give Berkshire the option to further increase its economic ownership without additional capital commitment today.
• $8.5 Billion in OXY Preferred Stock (8% Annual Dividend): Berkshire holds ~$8.5 billion of OXY cumulative perpetual preferred stock that pays 8% annual dividends — generating approximately $680 million per year in preferred dividends for Berkshire. This preferred stock was originally acquired as part of Berkshire's financing of OXY's 2019 Anadarko Petroleum acquisition. This preferred has priority over common shareholders in any distribution — and its 8% yield represents a meaningful ongoing capital cost for OXY.

For investors tracking Berkshire Hathaway's full portfolio and major institutional positions, InvestSnips covers the energy and financial sector compositions within major U.S. equity indexes.

CrownRock Acquisition: What It Means for OXY

The $12 billion CrownRock acquisition (closed Q1 2024) was the most significant strategic move in OXY's recent history — and the primary reason its debt load surged to levels requiring major asset divestitures including OxyChem.

What OXY Got

• 94,000 net acres in the Midland Basin (Permian): CrownRock's primary asset — high-quality, low-breakeven unconventional acreage in one of the best-performing areas of the U.S. oil patch
• ~170,000 BOE/d production addition: Immediately added significant production volume; the combined Permian position reached approximately 800,000 BOE/d
• 33% increase in sub-$40/bbl breakeven inventory: CrownRock's wells were among the most economic in the Permian, improving OXY's overall portfolio breakeven profile

How It Was Financed

• $9.1 billion of new debt
• $1.7 billion of common equity (new shares issued — dilutive to existing holders)
• $1.2 billion of assumed debt

Total pro forma debt jumped to approximately $28–$30 billion post-close, triggering an aggressive debt repayment mandate that continues through 2026–2027. The OxyChem sale to Berkshire was, in significant part, a direct response to this debt burden — using chemical asset value to rebuild balance sheet strength.

OxyChem Divestiture ($9.7B to Berkshire): Impact on OXY Stock

In early 2026, Berkshire Hathaway acquired OxyChem — Occidental's chemical division — for $9.7 billion. This divestiture is one of the most consequential strategic events in OXY's recent history. Understanding its dual impact is essential for investors:

Positive Impacts

• Massive debt reduction: OXY's primary stated use of proceeds is debt repayment — targeting principal debt declining to approximately $14.3 billion. This directly reduces interest expense burden (~$740 million in annual interest savings projected from cumulative debt repayments), improving free cash flow
• Credit rating uplift: Fitch upgraded OXY to BBB (from BBB-) in February 2026, citing accelerated execution of the debt reduction plan — a meaningful improvement enabling lower-cost future financing
• Simplified company structure: OXY becomes a more focused E&P + Carbon Management company, potentially attracting pure-play energy investors who previously discounted the chemical business as a regulatory/ESG complexity

Negative Impacts (Often Underappreciated)

• Loss of earnings diversification: OxyChem historically contributed $1–$2+ billion in annual net income during strong chemical market conditions — acting as a ballast against oil price volatility. Without it, OXY's earnings become more cyclical and oil-price-dependent
• 2026 revenue base reduction: Consensus 2026 revenue of ~$20.58 billion is lower than 2025's ~$22 billion — partly reflecting OxyChem's removal from the income statement
• Berkshire's sustained preferred income claim: The $8.5B preferred stock at 8% ($680M/year in preferred dividends) remains in place post-OxyChem sale — a significant ongoing cost to common shareholders

OXY Debt Reduction Journey: $13.9 Billion Repaid & Fitch Upgrade

OXY's debt reduction trajectory post-CrownRock is arguably the single most critical storyline for the stock's 2025–2026 investment thesis:

• $13.9 billion in debt repaid in the approximately 20 months following the CrownRock acquisition close (Q1 2024 → late 2025)
• $5.4 billion repaid year-to-date through early February 2026 (per Fitch's upgrade citation)
• ~$740 million in annualized interest expense reduction from cumulative debt repayments
• Current debt target: ~$14.3 billion principal following application of OxyChem proceeds
• Morgan Stanley projects OXY will reach its leverage target in late 2026 or early 2027
• Fitch upgraded OXY to BBB (stable) from BBB- in February 2026 — investment grade confirmation critical for institutional ownership and lower-cost future debt issuance

OXY Dividend: Yield, History & Sustainability

OXY's dividend track record reflects its sensitivity to oil cycles — it was a generous payer before the COVID-19 oil crash, slashed its dividend by ~86% in 2020 (from $0.79/quarter to $0.01/quarter), and has been gradually rebuilding since:

• Current annual dividend: ~$0.96/share ($0.24/quarter)
• Dividend yield (early 2026): ~2.0–2.2% forward at current prices
• Payout ratio: ~71.93% of trailing earnings
• Dividend safety: As long as WTI oil stays above ~$60/bbl and production targets are met, the current dividend appears manageable. Below $55–$60 sustained, the payout ratio could become strained given Berkshire's preferred dividend claim is structurally senior

Note: Berkshire's $8.5 billion preferred also receives 8% annual dividends (~$680M/year) — these are paid before OXY can return capital to common shareholders, effectively creating a capital structure layer that investors should factor into dividend sustainability analysis.

For investors tracking dividend yields and sustainability across U.S. energy and income-oriented equities, InvestSnips catalogs sector-level income characteristics across U.S. equity industries.

OXY Valuation: P/E, EV/EBITDA & Peer Comparison

Data approximate as of early 2026. Market caps, P/E ratios, and yields fluctuate daily. P/E ratios for OXY are particularly volatile due to commodity-driven earnings swings. Always verify at primary sources: Morningstar, Macrotrends, GuruFocus. This is not a buy/sell recommendation for any security.

OXY Oil Price Sensitivity & WTI Breakeven Analysis

Because OXY's earnings are now even more directly correlated to WTI crude oil prices post-OxyChem divestiture, understanding its oil price sensitivity is essential for any OXY investor.

Why OXY Is More Oil-Price-Sensitive Than XOM or CVX

• No integrated downstream: Unlike ExxonMobil (which profits from refining when oil is cheap) or Chevron (with diversified LNG), OXY's post-OxyChem business is almost entirely upstream E&P — providing no natural hedge against oil price declines
• Higher leverage: OXY's debt/EBITDA ratio (~2x including preferred) is significantly above XOM/CVX — meaning fixed debt costs consume more cash flow when oil prices fall
• Preferred stock obligation: Berkshire's $680M/year preferred dividend is a senior fixed claim, further reducing cash available to common shareholders in weak oil environments

OXY WTI Price Sensitivity Framework

• WTI above $80–85/bbl: OXY generates strong free cash flow (FCF), can accelerate debt reduction, increase buybacks, raise common dividend → most bullish scenario for common stock
• WTI at $65–80/bbl: Solid FCF; debt reduction continues on schedule; dividend and operations fully funded; Morgan Stanley's base case range
• WTI at $55–65/bbl: FCF tightens; debt reduction slows; common dividend potentially constrained; low-carbon ventures (including STRATOS DAC plant with high unit costs) face pressure
• WTI below $55/bbl sustained: FCF becomes negative in upper scenario; pressure builds on dividend; debt reduction stalls; preferred dividends remain but common stock value deteriorates. OXY management has referenced $60/bbl as a threshold below which funded low-carbon ventures become difficult to maintain

Use the OXY Oil Price Cash Flow Estimator below to model approximate income scenarios at different WTI price levels based on OXY's approximate production profile.

OXY Oil Price Cash Flow Estimator (Interactive)

Use this simplified model to estimate OXY's approximate gross upstream revenue sensitivity at different WTI price levels, based on OXY's 2026 production target of ~1.45 million BOE/d. This is a simplified educational model — actual OXY revenue includes hedging, gas/NGL pricing, opex, and corporate costs. Not a forecast or financial advice.

Key Risks of Investing in OXY Stock

1. Oil Price Risk (Primary Risk)

OXY's earnings and free cash flow are directly and heavily correlated to WTI crude oil prices. A sustained decline to $55/bbl or below would stress OXY's cash generation, potentially constrain the common dividend, slow debt reduction, and compress the stock's valuation multiple. This is the single most important risk for OXY investors — it cannot be diversified away within a single-stock OXY position.

2. Leverage Risk

Despite significant debt repayment progress, OXY remains more leveraged than peers like XOM and CVX. Debt/EBITDA of ~2x (including preferred) and interest coverage that was described as "pretty weak" in early 2026 (per analyst commentary) means a prolonged oil price downturn could create refinancing pressure — particularly against the backdrop of $24+ billion in total debt at peak. Fitch's BBB upgrade is positive, but the rating remains at the lower investment-grade band.

3. Berkshire Preferred — Structural Capital Cost

Berkshire Hathaway's $8.5 billion in OXY preferred stock pays 8% annually — approximately $680 million per year that is senior to common shareholder returns. Until this preferred is redeemed (at OXY's election, but at 110% of liquidation preference), it represents a structural drag on common stock economics. OXY has been making progress retiring this preferred — but it remains a significant overhang.

4. OxyChem Earnings Void

As discussed, OXY no longer has OxyChem to stabilize earnings during oil price weakness. Investors who owned OXY partly for earnings stability through the chemical business must reassess their risk model — the post-divestiture company is more cyclical, more volatile, and more correlated to oil prices than before.

5. Carbon Management / STRATOS Execution Risk

OXY has invested significantly in STRATOS — the world's largest Direct Air Capture (DAC) plant in West Texas, operational since 2024. DAC technology remains expensive ($300–$1,000+ per ton of CO₂ removed at current technology costs), and OXY's ability to sell carbon credits at profitable prices is uncertain. If the voluntary carbon market or government incentive programs (45Q tax credits) underperform expectations, STRATOS could be a drag rather than an asset driver.

6. Dilution Risk from Berkshire Warrants

Berkshire holds warrants to purchase additional OXY shares at a fixed price. If exercised, these warrants create additional dilution for existing common shareholders — reducing per-share earnings and cash flow metrics. The strike price of Buffett's warrants vs. OXY's market price determines if/when this is economically rational for Berkshire.

OXY vs. Peers: How Occidental Compares to XOM, CVX, COP, DVN

Investors considering OXY should evaluate it against comparable E&P and integrated energy companies. The peer table above covers key metrics. Key qualitative differentiators:

• OXY vs. XOM: XOM is vastly larger, far lower-leverage, pays a higher dividend yield (~3.4–3.7%), and has full downstream integration insulating earnings from pure-play oil price swings. XOM is a classic "sleep well at night" energy position; OXY offers higher leverage (and upside/downside) to oil price moves
• OXY vs. CVX: Similar dynamic — CVX's fortress balance sheet and higher yield make it the defensive choice; OXY is the more aggressive Permian-leveraged bet
• OXY vs. COP: ConocoPhillips (COP) is the closest pure-play E&P peer, with better balance sheet health (~0.38x debt/equity vs. OXY's 0.63–0.88x), lower valuation, and slightly better FCF yield. COP's Marathon Oil acquisition (2024) added similar Permian scale; the key differentiator is OXY's Buffett endorsement and carbon management exposure
• OXY vs. DVN: Devon's variable dividend model returns more FCF to shareholders when oil is high; OXY is the choice for investors specifically seeking Permian scale and Buffett confidence

For how OXY, XOM, CVX, and COP are categorized within the energy sector across U.S. index products and ETFs, see InvestSnips' ETF coverage across major U.S. asset classes and sectors.

OXY 2025–2026 Outlook

Bullish Catalysts

• Continued debt reduction reaching Morgan Stanley's leverage target (late 2026 / early 2027) frees substantial FCF for common shareholders
• Fitch BBB upgrade (Feb 2026) reduces future debt issuance cost; potential for S&P/Moody's upgrades to follow
• 2026 CapEx reduction of ~$550M vs. 2025 improves FCF conversion at same production levels
• WTI oil at $75–85/bbl would significantly exceed consensus cash flow assumptions — OXY benefits disproportionately vs. lower-leverage peers at high oil prices
• STRATOS DAC plant carbon credit monetization — if 45Q tax credit incentives remain strong and voluntary carbon markets mature, could become a meaningful ancillary value driver
• Potential Berkshire full acquisition — remains a speculative but rational optionality given Berkshire's multi-layer position

Bearish Catalysts

• WTI oil below $60/bbl sustained would stress all financial targets simultaneously
• Preferred stock cash drain ($680M/year to Berkshire) before common returns
• Full Berkshire takeover at a price below current market could disappoint non-Berkshire shareholders (though unlikely without a premium)
• DAC/STRATOS cost overruns or regulatory/credit market headwinds on carbon credits

Frequently Asked Questions About OXY Stock